XM does not provide services to residents of the United States of America.
G
G

Getinge


News

FDA Highlights Safety Concerns & Class I Recall for Getinge's Vasoview Hemopro Devices

BRIEF-FDA Highlights Safety Concerns & Class I Recall for Getinge's Vasoview Hemopro Devices Nov 15 (Reuters) - FDA: FDA: ALERTING HEALTH CARE PROVIDERS ABOUT SAFETY CONCERNS WITH GETINGE/MAQUET VASOVIEW HEMOPRO EVH SYSTEMS AND SUPPLY CONCERN FOR EVH DEVICES- WEBSITE FDA: WORKING WITH MANUFACTURER TO EVALUATE REPORTS OF SILICONE DETACHMENT WITH VAS
G

Barratt Redrow, Genuit Group, Munich Re

EUROPE RESEARCH ROUNDUP-Barratt Redrow, Genuit Group, Munich Re Oct 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Barratt Redrow, Genuit Group and Munich Re, on Monday. HIGHLIGHTS * Barratt Redrow Plc BTRW.L : Morgan Stanley raises to overweight from equal-weight * Genuit Group Plc GENG.L : JP Morgan initiates coverage with neutral rating; PT 535p * Intertek ITRK.L : RBC cuts to sector perform from outperform * Munich Re MUVGn.
B
B
B
B
B
C
D
D
E
E
E
F
G
N
O
R
S
A
P

Europe's STOXX 600 ends week higher as tech stocks rebound

UPDATE 2-Europe's STOXX 600 ends week higher as tech stocks rebound For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Luxury stocks aid gains on France's CAC 40 Elisa slumps on unexpected Q3 revenue fall Goldman Sachs slashes STOXX 600 2024 earnings growth forecast STOXX 600 up 0.2% Updated at 1602 GMT By Paolo Laudani, Ankika Biswas and Johann M Cherian Oct 18 (Reuters) - Europe's STOXX 600 ended higher on Friday, as tech stocks made a s
B
D
G
G
H
I
K
L
R
V
A
S
E
F
G

Europe before the bell: A calmer end to the week

LIVE MARKETS-Europe before the bell: A calmer end to the week Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EUROPE BEFORE THE BELL: A CALMER END TO THE WEEK European stocks are in for a tepid end to the week, as traders ramp up bets on more ECB rate cuts after Thursday's and digest some less than stellar data out of China.
G
N
V
E
F
U
G

Getinge Keeps 2024 Outlook Unchanged

BRIEF-Getinge Keeps 2024 Outlook Unchanged Oct 18 (Reuters) - Getinge AB GETIb.ST : TEMPORARY DELIVERY DISRUPTIONS HAD A NEGATIVE IMPACT ON EARNINGS BIO-PROCESSING WITH DOUBLE-DIGIT GROWTH IN ORGANIC ORDER INTAKE BOTH IN US AND IN CHINA IN Q3 OUTLOOK 2024: NET SALES FOR 2024 ARE EXPECTED TO INCREASE BY 2–5% ORGANICALLY (UNCHANGED) ORGANIC SALES F
G

Getinge misses Q3 forecasts, weighed by quality and delivery issues

UPDATE 3-Getinge misses Q3 forecasts, weighed by quality and delivery issues Q3 adj. EBITA and sales miss analysts' forecasts Orders keep growing organically at 7.4% Deliveries restarted after temporary disruptions in Q3, CEO says Shares fall 6.9% by midday local time Adds sales miss in paragraph 1, shares and analyst comment in paragraphs 6-7, CEO quotes from interview in paragraphs 4,10,12 By Greta Rosen Fondahn Oct 18 (Reuters) - Swedish medical equipment maker Getinge GETIb.ST missed forecas
G

Medical gear maker Getinge's Q3 core profit misses expectations

Medical gear maker Getinge's Q3 core profit misses expectations Oct 18 (Reuters) - Swedish medical equipment maker Getinge GETIb.ST reported core earnings below expectations for the third quarter on Friday, while it struggles to resolve prolonged quality problems with some of its heart products. Reporting by Greta Rosen Fondahn in Gdansk; editing b
G

Europe's STOXX 600 corporate earnings week ahead

DIARY-Europe's STOXX 600 corporate earnings week ahead Oct 11 (Reuters) - Diary of Europe's STOXX 600 (.STOXX) corporate earnings for the week ahead EUROPE'S STOXX 600 EARNINGS Start Date Start Time(GMT) RIC Company Name Event Name 15-Oct-2024 BMO BWY.L Bellway PLC Full Year 2024 Bellway PLC Earnings Release 15-Oct-2024 05:00 ERICb.ST Telefonaktiebolaget LM Ericsson Q3 2024 Telefonaktiebolaget LM Ericsson Earnings Release 16-Oct-2024 AMC GFCP.PA Gecina SA Q3 2024 Gecina SA Earnings Release 16-Oc
A
B
E
E
G
G
I
K
N
R
V
W
A

Nordic corporate earnings week ahead

DIARY-Nordic corporate earnings week ahead Oct 11 (Reuters) - Diary of Nordic (OMXS30-SK, OBX-OS, OMXHPI-HE, OMXC20) corporate earnings for the week ahead NORDIC EARNINGS Start Date Start Time(GMT) RIC Company Name Event Name 15-Oct-2024 05:00 ERICb.ST Telefonaktiebolaget LM Ericsson Q3 2024 Telefonaktiebolaget LM Ericsson Earnings Release 16-Oct-2024 06:00 KINVb.ST Kinnevik AB Q3 2024 Kinnevik AB Earnings Release 17-Oct-2024 05:00 ABBN.S Abb Ltd Q3 2024 Abb Ltd Earnings Release 18-Oct-2024 06:0
A
E
E
G
K
N
V

Getinge's CE Certificate For ECLS Consumables Reinstated

BRIEF-Getinge's CE Certificate For ECLS Consumables Reinstated Sept 25 (Reuters) - Getinge AB GETIb.ST : GETINGE’S CE CERTIFICATE FOR ECLS CONSUMABLES REINSTATED TEMPORARY CHALLENGES RELATED TO NEW PACKAGING SOLUTION RESULTED IN LOWER VOLUME OF HLS AND PLEASE SETS AVAILABLE FOR SHIPMENT IN Q3 2024 TÜV SÜD REINSTATES GETINGE’S CE CERTIFICATE F
G

ASOS, JTC, London Stock Exchange

EUROPE RESEARCH ROUNDUP-ASOS, JTC, London Stock Exchange Sept 19 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including ASOS, JTC and London Stock Exchange, on Thursday. HIGHLIGHTS * ASOS Plc ASOS.L : HSBC cuts to reduce from hold * JTC Plc JTC.L : RBC raises target price to 1,100p from 980p * London Stock Exchange LSEG.L : HSBC raises target price to 10,000p from 9,400p * Nordic Semiconductor ASA NOD.OL : Barclays cuts target price to NOK
A
A
A
A
A
A
B
C
E
E
F
G
H
L
N
N
N
S
S
S
T
T
A
A
A
A
N
R

Getinge CEO Buys Shares

BRIEF-Getinge CEO Buys Shares Sept 5(Reuters) - Getinge AB GETIb.ST : SAID ON WEDNESDAY CEO OF GETINGE AB MATTIAS PERJOS BUYS 20,000 SHARES AT PRICE ABOUT SEK 218.0771 PER SHARE ON SEPTEMBER 4TH Source text for Workspace: [ Full Story ] Further company coverage: [GETIb.ST] (Gdansk Newsroom)
G

Getinge Makes A Provision Of MBRL 240 Related To Brazilian Investigation

BRIEF-Getinge Makes A Provision Of MBRL 240 Related To Brazilian Investigation Sept 1 (Reuters) - Getinge AB GETIb.ST : GETINGE MAKES A PROVISION OF MBRL 240 RELATED TO BRAZILIAN INVESTIGATION GETINGE - FINAL AND DEFINITIVE COSTS WILL BE DETERMINED WHEN SETTLEMENT NEGOTIATIONS ARE CONCLUDED GETINGE - PROVISION WILL BE REPORTED AS AN ITEM AFFECTING
G

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Updates: Schenker Aug 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Friday: ** Deutsche Bahn's logistics unit Schenker has received final bids from Danish transport firm DSV DSV.CO and a consortium led by CVC Capital Partners CVC.AS , with each valuing the business at around 14 billion euros ($15.6 billion), two people familiar with the matter told Reuters.
G

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Aug 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Friday: ** Deutsche Bahn's logistics unit Schenker has collected final bids from a consortium led by CVC Capital Partners CVC.AS and Danish transport firm DSV DSV.CO that value the business at around 14 billion euros ($15.57 billion), two people familiar with the matter told Reuters.
G

Paragonix Technologies Signs Definitive Agreement To Be Acquired By Getinge

BRIEF-Paragonix Technologies Signs Definitive Agreement To Be Acquired By Getinge Aug 22 (Reuters) - Getinge AB GETIb.ST : PARAGONIX TECHNOLOGIES SIGNS DEFINITIVE AGREEMENT TO BE ACQUIRED BY GETINGE Source text for Eikon: ID:nBw6XvskYa Further company coverage: [GETIb.ST]
G

Getinge To Acquire Paragonix Technologies

BRIEF-Getinge To Acquire Paragonix Technologies Aug 22 (Reuters) - Getinge AB GETIb.ST : GETINGE TO ACQUIRE PARAGONIX TECHNOLOGIES, A GROWTH LEADER IN THE ORGAN TRANSPLANTATION MARKET GETINGE- PROPOSED DEAL FOR APPROXIMATELY USD 477 MILLION. Source text for Eikon: ID:nPnblMm1na Further company coverage: [GETIb.ST]
G

Swedish firm Getinge to buy Paragonix Technologies for about $477 mln

Swedish firm Getinge to buy Paragonix Technologies for about $477 mln Aug 22 (Reuters) - Swedish medical-equipment maker Getinge GETIb.ST said on Thursday it will acquire U.S.-based organ transport company Paragonix Technologies for about $477 million. Getinge will acquire all the issued and outstanding shares of the privately-held Paragonix on a cash and debt-free basis, adding that the initial payout related to the acquisition will be financed through a bridge loan provided by Swedish bank SEB
G

Getinge Says Co To Acquire Paragonix Technologies For USD 477 Mln

BRIEF-Getinge Says Co To Acquire Paragonix Technologies For USD 477 Mln Aug 22 (Reuters) - Getinge AB GETIb.ST : GETINGE TO ACQUIRE PARAGONIX TECHNOLOGIES, A GROWTH LEADER IN THE ORGAN TRANSPLANTATION MARKET GETINGE AB - ACQUIRES PARAGONIX TECHNOLOGIES FOR USD 477 MILLION GETINGE - AGGREGATED UPFRONT PURCHASE PRICE OF $477 MILLION, OF WHICH USD 253
G



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.